Herke van HulstPartner at Osborne ClarkeHost
Profile
Herke specializes in venture capital, private equity, mergers & acquisitions, joint ventures and advises clients on corporate governance and other corporate law issues.
Herke has a broad transactional and corporate advisory practice. She has extensive experience in transactions in Healthcare & Life Sciences and TMC. Clients include national and international private equity and venture capital firms, investment funds and national and international corporate clients.
"She is an excellent communicator, proactive and in charge of the processes. She has an eye for detail and gives advice and not just options."
"Herke van Hulst is available with sound legal and tactical advice. We value her deep knowledge and expertise."
Chambers and Partners 2024
Herke is a graduate of the University of Utrecht and studied law at Panthéon-Assas in Paris. She was admitted to the Dutch bar in 1996. Prior to joining Osborne Clarke in December 2015, Herke was Counsel at Clifford Chance LLP in Amsterdam where she worked for 15 years.
Over the course of her career Herke worked from Amsterdam, London and Kuala Lumpur.
Herke is ranked in the Legal 500 and Chambers & Partners.
Chambers & Partners Global 2024 regonizes Herke as Notable Practitioner: "Herke van Hulst is available with sound legal and tactical advice. We value her deep knowledge and expertise."
Legal 500 mentions Herke as a ‘Highly talented, pragmatic’ Healthcare & Life Sciences expert and reported her as 'skilled, supportive'.
Herke has registered the following principal (and secondary) legal practice areas in the Netherlands Bar’s register of legal practice areas (rechtsgebiedenregister):
- Corporate Law
- Companies
- Associations and Foundations
- Mergers and Acquisitions
- Director's liability
Based on this registration, she is required to obtain ten training credits per calendar year in each registered principal legal practice area in accordance with the standards set by the Netherlands Bar.
'Herke van Hulst is proactive, outcome-oriented, in control of processes, a great communicator, energetic, responsive and a leader, not just a facilitator.’
Legal 500
Agenda Sessions
Getting Drugs to Patients Faster - Investing in Discovery, Development & Clinical Trial Tech
, 14:00View Session